PT  - JOURNAL ARTICLE
AU  - F S Y Fan
AU  - K M Chow
AU  - C C Szeto
AU  - P K T Li
TI  - Hyperchloraemic metabolic acidosis
AID  - 10.1136/emj.2008.059923
DP  - 2008 Sep 01
TA  - Emergency Medicine Journal
PG  - 613--613
VI  - 25
IP  - 9
4099  - http://emj.bmj.com/content/25/9/613.short
4100  - http://emj.bmj.com/content/25/9/613.full
SO  - Emerg Med J2008 Sep 01; 25
AB  - Cholestyramine carries a risk of hyperchloraemic metabolic acidosis. Being cognisant of this drug-induced adverse event may reduce diagnostic delays. Emergency physicians should be alert about this condition, in particular among patients with pre-existing chronic kidney disease, or who are taking spironolactone.